Patents by Inventor Christopher Lopes

Christopher Lopes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LONG-ACTING NATRIURETIC PEPTIDES AND USES THEREOF
    Publication number: 20240174727
    Abstract: The present invention relates to Atrial Natriuretic Peptide (ANP) polypeptides and methods of treatment with ANP polypeptides.
    Type: Application
    Filed: October 19, 2023
    Publication date: May 30, 2024
    Inventors: Jorge ALSINA-FERNANDEZ, Hana Elisabeth BAKER, Guillermo S. CORTEZ, Michael Lawrence ELMUCCIO, Wen LIU, Daniel Christopher LOPES, Avinash MUPPIDI, Francisco Alcides VALENZUELA, Yan WANG, Lin ZHANG
  • Protein tyrosine-tyrosine analogs and methods of using the same
    Patent number: 11820803
    Abstract: PYY analogs are disclosed that include modifications that increase half-life when compared to native, human PYY, as well as additional modifications that increase potency and selectivity to the NPY2 receptor. Pharmaceutical compositions also are disclosed that include one or more of the PYY analogs described herein in a pharmaceutically acceptable carrier. Methods of making and using the PYY analogs also are disclosed, especially for treating obesity and obesity-related diseases and disorders such as type II diabetes mellitus.
    Type: Grant
    Filed: October 5, 2021
    Date of Patent: November 21, 2023
    Assignee: Eli Lilly and Company
    Inventors: Daniel Anthony Briere, Daniel Christopher Lopes, Avinash Muppidi
  • PROTEIN TYROSINE-TYROSINE ANALOGS AND METHODS OF USING THE SAME
    Publication number: 20220025009
    Abstract: PYY analogs are disclosed that include modifications that increase half-life when compared to native, human PYY, as well as additional modifications that increase potency and selectivity to the NPY2 receptor. Pharmaceutical compositions also are disclosed that include one or more of the PYY analogs described herein in a pharmaceutically acceptable carrier. Methods of making and using the PYY analogs also are disclosed, especially for treating obesity and obesity-related diseases and disorders such as type II diabetes mellitus.
    Type: Application
    Filed: October 5, 2021
    Publication date: January 27, 2022
    Inventors: Daniel Anthony Briere, Daniel Christopher Lopes, Avinash Muppidi
  • Protein tyrosine-tyrosine analogs and methods of using the same
    Patent number: 11155592
    Abstract: PYY analogs are disclosed that include modifications that increase half-life when compared to native, human PYY, as well as additional modifications that increase potency and selectivity to the NPY2 receptor. Pharmaceutical compositions also are disclosed that include one or more of the PYY analogs described herein in a pharmaceutically acceptable carrier. Methods of making and using the PYY analogs also are disclosed, especially for treating obesity and obesity-related diseases and disorders such as type II diabetes mellitus.
    Type: Grant
    Filed: October 28, 2019
    Date of Patent: October 26, 2021
    Assignee: Eli Lilly and Company
    Inventors: Daniel Anthony Briere, Daniel Christopher Lopes, Avinash Muppidi
  • PROTEIN TYROSINE-TYROSINE ANALOGS AND METHODS OF USING THE SAME
    Publication number: 20200140514
    Abstract: PYY analogs are disclosed that include modifications that increase half-life when compared to native, human PYY, as well as additional modifications that increase potency and selectivity to the NPY2 receptor. Pharmaceutical compositions also are disclosed that include one or more of the PYY analogs described herein in a pharmaceutically acceptable carrier. Methods of making and using the PYY analogs also are disclosed, especially for treating obesity and obesity-related diseases and disorders such as type II diabetes mellitus.
    Type: Application
    Filed: October 28, 2019
    Publication date: May 7, 2020
    Inventors: Daniel Anthony Briere, Daniel Christopher Lopes, Avinash Muppidi
  • Ring
    Patent number: D908522
    Type: Grant
    Filed: July 6, 2018
    Date of Patent: January 26, 2021
    Assignee: Richemont International SA
    Inventor: Christopher Lopes